Incon Co., Ltd. - Net Worth and Insider Trading

Incon Co., Ltd. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Incon Co., Ltd. owns 1 companies in total, including ZyVersa Therapeutics Inc (ZVSA) .

Click here to see the complete history of Incon Co., Ltd.’s form 4 insider trades.

Insider Ownership Summary of Incon Co., Ltd.

Ticker Comapny Transaction Date Type of Owner
ZVSA ZyVersa Therapeutics Inc 2022-12-12 10 percent owner

Incon Co., Ltd. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Incon Co., Ltd. Ownership Network

Ownership Network List of Incon Co., Ltd.

No Data

Ownership Network Relation of Incon Co., Ltd.

Insider Network Chart

Incon Co., Ltd. Owned Company Details

What does ZyVersa Therapeutics Inc do?

Who are the key executives at ZyVersa Therapeutics Inc?

Incon Co., Ltd. is the 10 percent owner of ZyVersa Therapeutics Inc. Other key executives at ZyVersa Therapeutics Inc include Chief Medical Officer Pablo A. Guzman , director & Chief Executive Officer Stephen C. Glover , and Chief Scientific Officer Labella Nicholas A. Jr. .

ZyVersa Therapeutics Inc (ZVSA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of ZyVersa Therapeutics Inc (ZVSA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ZyVersa Therapeutics Inc (ZVSA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ZyVersa Therapeutics Inc (ZVSA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

ZyVersa Therapeutics Inc Insider Transactions

No Available Data

Incon Co., Ltd. Mailing Address

Above is the net worth, insider trading, and ownership report for Incon Co., Ltd.. You might contact Incon Co., Ltd. via mailing address: 4/f 16-17 Ls-ro 91beon-gil, Dongan-gu Anyang, Gyeonggi M5 14042.

Discussions on Incon Co., Ltd.

No discussions yet.